Kapruvia Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

kapruvia

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - Öll önnur lækningavörur - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

Oxbryta Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

oxbryta

pfizer europe ma eeig  - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.

Hemgenix Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

hemgenix

csl behring gmbh - etranacogene dezaparvovec - hemophilia b - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.

Sotyktu Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

sotyktu

bristol-myers squibb pharma eeig - deucravacitinib - psoriasis - Ónæmisbælandi lyf - treatment of moderate-to-severe plaque psoriasis in adults.

Fosrenol Tuggutafla 750 mg Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

fosrenol tuggutafla 750 mg

takeda pharmaceuticals international ag ireland branch - lanthanum karbónat - tuggutafla - 750 mg

Fosrenol Tuggutafla 500 mg Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

fosrenol tuggutafla 500 mg

takeda pharmaceuticals international ag ireland branch - lanthanum karbónat - tuggutafla - 500 mg

Daivobet Hlaup 50 míkróg/g /0,5 mg/g Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

daivobet hlaup 50 míkróg/g /0,5 mg/g

leo pharma a/s* - calcipotriolum inn; betamethasonum díprópíónat - hlaup - 50 míkróg/g /0,5 mg/g